Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-13

Clinical Trial Update: Effect of Oral L-arginine 3.32 g a Day on Oxidative Stress Influencing Beta Cell Function and Insulin Resistance. [NA]

View source ↗

Summary

A clinical trial from Federico II University is evaluating whether daily oral L-arginine (3.32 g) reduces oxidative stress and improves beta-cell function and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arginine (L-Arginine)

Snippet

Sponsor: Federico II University | Conditions: Diabetes, Pre-diabetes | NA | Status: NOT_YET_RECRUITING